SoFi shares rise as record revenue, member growth drive strong Q3 results
Investing.com -- Vimian reported third-quarter 2025 results that exceeded market expectations, with net revenue increasing 19% year-over-year to €104.3 million, 1% above Modular Finance consensus.
The company achieved 9% organic growth during the quarter, primarily driven by strong performance in its Specialty Pharma and Veterinary Services segments, both of which delivered 11% organic growth.
The MedTech segment returned to organic growth of 5% in the quarter, despite facing continued softness in the US surgery market. Meanwhile, the Diagnostics segment grew 4% organically.
Adjusted EBITA increased 17% year-over-year to €25.5 million, surpassing consensus estimates by 5%. This resulted in an adjusted EBITA margin of 24.5%, representing a slight decrease of 0.5 percentage points compared to the same period last year.
Following the announcement, Vimian’s shares rose 7% in trading.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.